Saxagliptin

BreastfeedingPediatric
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:

ACE inhibitors, Alcohol, Aprepitant, Beta blockers, Bexarotene, Colchicine, Conivaptan, Corticosteroids, CYP3A4 inducers, Darunavir, Dasatinib, Delavirdine, Diazoxide, Diuretics, Efavirenz, Estradiol, Estrogens, Hypoglycemic agents, Indinavir, Ketoconazole, Lapatinib, MAO inhibitors, Oxcarbazepine, P-glycoprotein inhibitors and inducers, Pegvisomant, Pioglitazone, Rifapentine, Somatropin, Strong CYP3A4/5 inhibitors, Telithromycin, Terbinafine, Testosterone, Voriconazole

PREGNANCY CATEGORY: B

Qtern is saxagliptin and dapagliflozin.

Our database has 42 adverse reactions for this drug across the following areas

Please login to see the rest of this drug profile


Not a subscriber? Click here to subscribe

SKIN
CARDIOVASCULAR
CENTRAL NERVOUS SYSTEM
ENDOCRINE/METABOLIC
GASTROINTESTINAL/HEPATIC
GENITOURINARY
HEMATOLOGIC
NEUROMUSCULAR/SKELETAL
RENAL
RESPIRATORY
OTHER


Visit Informa

Click on the DRUG REVIEW ARTICLE tab (above) to see a review of saxagliptin in the Taylor & Francis journal Expert Opinion on Drug Safety. (Note that non-subscribers to the journal will only be able to see an abstract of the article.)

Page last updated 12/03/2018

Drug Eruption Mobile Site

Symbol key

Incidence info

  • <1%
  • 1-5%
  • 5-10%
  • 10-15%
  • 15-20%
  • 20-30%
  • >30%

Seriousness info

  • Hospitalization possible
  • Life threatening
  • Fatal

Warnings in other populations info

  • Breast feeding
  • Geriatric
  • Pediatric
^ Back to top